Macrilen Granule, For Solution
Product Images NDC 0169-1401

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Macrilen (NDC 0169-1401). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novo Nordisk, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Image 01)

Macrilen 60 mg granule for oral solution packaging label. The label includes the proprietary name Macrilen and the generic name macimorelin acetate, indicating it is for oral use. The labeler is Novo Nordisk and the product is distributed by Novo Nordisk Inc., Plainsboro, NJ, USA. The packaging contains one pouch and provides instructions for use and disposal. The label also includes manufacturer information from Alipharmed Pharbil Arzneimittel GmbH, Germany.*

FDA Label Image

Figure 1 (Structure)

Chemical structure diagram of macimorelin acetate, the active ingredient in Macrilen. The structure includes the molecular components and indicates the presence of acetic acid (CH3COOH) associated with the compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.